I. Latorzeff

5.6k citations
149 papers · 3.9k · 3 hit papers · h-index 22

Impact in

Papers in

I. Latorzeff

127 papers receiving 3.8k citations

I. Latorzeff's Hit Papers

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design 2022 · 560 citations
5600+4+8Years since publication100200300400500

Peers

I. Latorzeff
Comparison fields: 5 of 77
  • Pulmonary and Respiratory Medicine 3k
  • Radiation 496
  • Radiology, Nuclear Medicine and Imaging 206
  • Cancer Research 102
  • Oncology 148
Replace Zafar Malik with:
Zafar Malik United Kingdom
Julian Money‐Kyrle United Kingdom
Omar Sadeeq Din United Kingdom
James Pinson Wylie United Kingdom
Pierre M. Richaud France
Stan Rosenfeld United States
Chris Brawley United Kingdom
Carlos Vargas United States
Varagur Venkatesan Canada
Patrick Cheung Canada
I. Latorzeff relative to Zafar Malik United Kingdom Zafar Malik's profile →
Citations per field
00.5×1.5×2.0×
Zafar Malik · 1×
Citations per year

Countries citing papers authored by I. Latorzeff

Since Specialization
Citations

This map shows the geographic impact of I. Latorzeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Latorzeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Latorzeff more than expected).

Fields of papers citing papers by I. Latorzeff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Latorzeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Latorzeff. The network helps show where I. Latorzeff may publish in the future.

Co-authors

The 25 scholars most cited alongside I. Latorzeff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I. Latorzeff Line = papers co-authored together I. Latorzeff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2013575
2
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Hit paper breakdown →
2022560
3
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015378
4 2016275
5 2020256
6 2020212
7 2019176
8 2019134
9 2014102
10 201889
11 201669
12 202169
13 201455
14 201753
15 201043
16 201536
17 202136
18 201832
19 202130
20 202129

About I. Latorzeff

I. Latorzeff is a scholar working on Pulmonary and Respiratory Medicine, Radiation, Cancer Research, Surgery and Urology, having authored 149 papers that have together received 3.9k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (64 papers), Advanced Radiotherapy Techniques (40 papers), Prostate Cancer Treatment and Research (24 papers), Brain Metastases and Treatment (10 papers), Bladder and Urothelial Cancer Treatments (7 papers), Breast Cancer Treatment Studies (7 papers), Management of metastatic bone disease (6 papers) and Urinary Tract Infections Management (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3k citations), Radiation (496 citations), Radiology, Nuclear Medicine and Imaging (206 citations), Cancer Research (102 citations) and Oncology (148 citations). I. Latorzeff has collaborated with scholars based in France, Canada and Switzerland. Frequent co-authors include Paul Sargos, Stéphane Supiot, Pierre M. Richaud, Michel Soulie, Dominique Pasquier, R. de Crevoisier, Meryem Brihoum, Sylvie Chabaud, G. Créhange and Pascal Pommier. Their work appears in journals such as Frontiers in Oncology, International Journal of Radiation Oncology*Biology*Physics, The Lancet Oncology, European Urology and Physica Medica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact